Results 201 to 210 of about 2,434,856 (285)
The Role of Astrocytes in the Inflammatory Response in Neurodiseases
Reactive astrocyte‐mediated pathogenic mechanisms in neurodegenerative diseases Schematic representation of key astrocytic pathways contributing to pathology in the pathogenesis of AD, PD, ALS, and HD. In AD, astrocytes exhibit Aβ plaque‐associated activation characterized by GFAP/S100β upregulation, accompanied by impaired EAAT2‐mediated glutamate ...
Shijun Peng +3 more
wiley +1 more source
A metabolite morphogen coordinates multicellular development in <i>Bacillus subtilis</i>. [PDF]
Updegrove TB +11 more
europepmc +1 more source
Sepsis: Epidemiology, Pathophysiology, and Management
Sepsis remains a major global health burden characterized by substantial geographical heterogeneity and a considerable disease burden in China. Its pathophysiology reflects an interconnected network involving excessive inflammation, oxidative stress, immune imbalance and immunoparalysis, mitochondrial damage, endothelial injury, gut dysbiosis ...
Guang‐Tao Pan +8 more
wiley +1 more source
Field strains of the unicellular alga Chlamydomonas reinhardtii exhibit multicellular characteristics that shape their interactions. [PDF]
Lingappa UF +10 more
europepmc +1 more source
Alzheimer's Disease: Mechanisms and Therapeutic Advances
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu +4 more
wiley +1 more source
A quorum-sensing molecule from <i>Pseudomonas aeruginosa</i> induces defensive multicellularity in a coinfecting pathogen. [PDF]
Katharios-Lanwermeyer S +6 more
europepmc +1 more source
Thinking about Bacillus subtilis as a multicellular organism.
Claudio Aguilar +3 more
semanticscholar +1 more source
ABSTRACT Chitinase‐3‐like‐1 (CHI3L1, also known as YKL‐40) has been recognized as a biomarker of inflammation and tissue remodeling and has now emerged as a pseudoenzymatic immune checkpoint. Recent structural, immunological, and translational studies redefine it as an active regulator of immune suppression rather than a passive disease marker. Despite
Kirti Upmanyu +2 more
wiley +1 more source
Aggregative chimeric multicellularity in the absence of lethal kin discrimination. [PDF]
Weltzer ML, Roy PC, Govaerts J, Wall D.
europepmc +1 more source

